Panulisib

N/A

Report date: 2024/10/16 17:28:34
NME

Base Information

Drug NamePanulisib
Drug Alias NameP-7170
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsmTOR Complex 2 inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors +[4] 
TargetsMammalian target of Rapamycin (mTORC1)mTOR Complex 2PI3-kinase class I +[4] 
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPiramal Phytocare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPiramal Enterprises Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A